EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

FURIN, IFNL4, and TLR2 gene polymorphisms in relation to COVID-19 severity: a case–control study in Egyptian patients

Gamalat A Elgedawy, Naglaa S Elabd, Radwa H Salem, Samah M Awad, Amany A Amer, Mohammad M Torayah, Amal A El-Koa, Mai Abozeid, Belal A Montaser, Hind S Aboshabaan, Mervat Abdelkreem, Marwa L Helal

Infection · 2024

DOI: 10.1007/s15010-024-02266-1 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Infection, 2024. Verfasst von Gamalat A Elgedawy und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Biochemistry and Molecular Diagnostics, National Liver Institute, Menoufia University, Shebin El-Kom, Menoufia, Egypt. Hauptthemen laut MEDLINE: COVID-19, Toll-Like Receptor 2, Furin, SARS-CoV-2. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Minufiya University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Aim A wide range of clinical manifestations and outcomes, including liver injury, have been reported in COVID-19 patients. We investigated the association of three substantial gene polymorphisms ( FURIN , IFNL4 , and TLR2 ) with COVID-19 disease susceptibility and severity to help predict prognosis.

Methods

150 adult COVID-19-assured cases were categorized as follows: 78 patients with a non-severe presentation, 39 patients with severe disease, and 33 critically ill patients. In addition, 74 healthy controls were included. Clinical and laboratory evaluations were carried out, including complete and differential blood counts, D-dimer, lactate dehydrogenase (LDH), C-reactive protein (CRP), procalcitonin, ferritin, interleukin-6 (Il-6), and liver and kidney functions. FURIN (rs6226), IFNL4 (rs12979860), and TLR2 (rs3804099) genotyping allelic discrimination assays were conducted using real-time PCR.

Results

The FURIN , IFNL4 , and TLR2 genotypes and their alleles differed significantly between COVID-19 patients and controls, as well as between patients with severe or critical illness and those with a non-severe presentation. According to a multivariable regression analysis, FURIN (C/T + T/T) and TLR2 (T/C + C/C) mutants were associated with COVID-19 susceptibility, with odds ratios of 3.293 and 2.839, respectively. FURIN C/C and IFNL4 T/T mutants were significantly linked to severe and critical illnesses. Multivariate regression analysis showed that FURIN (G/C + C/C) genotypes and IFNL4 T/T homozygosity were independent risk factors associated with increased mortality.

Conclusion

FURIN , IFNL4 , and TLR2 gene variants are associated with the risk of COVID-19 occurrence as well as increased severity and poor outcomes in Egyptian patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19Toll-Like Receptor 2FurinSARS-CoV-2Severity of Illness IndexHumansMaleFemaleEgyptCase-Control StudiesMiddle AgedAdultGenetic Predisposition to DiseaseInterleukinsPolymorphism, Single NucleotideGenotypeInterferon Lambda

Stichwörter der Autor:innen

FURINIFNL4TLR2AllelesGene variantsGenotypes

Substanzen

Toll-Like Receptor 2FurinTLR2 protein, humanIFNL4 protein, humanInterleukinsFURIN protein, humanInterferon Lambda

Autor:innen und Institutionen

  • Department of Clinical Biochemistry and Molecular Diagnostics, National Liver Institute, Menoufia University, Shebin El-Kom, Menoufia, Egypt.
  • Faculty of Medicine, Department of Tropical Medicine, Menoufia University, Shebin El-Kom, Menoufia, 32511, Egypt. naglaa.alabd.12@med.menofia.edu.eg.
  • Department of Clinical Microbiology and Immunology, National Liver Institute, Menoufia University, Shebin El-Kom, Menoufia, Egypt.
  • Faculty of Medicine, Department of Tropical Medicine, Menoufia University, Shebin El-Kom, Menoufia, 32511, Egypt.
  • Faculty of Medicine, Department of Critical Care Medicine, Menoufia University, Shebin El-Kom, Egypt.
  • Faculty of Medicine, Department of Chest Diseases and Tuberculosis, Menoufia University, Shebin El‑Kom, Menoufia, Egypt.

Förderung

  • Minufiya University

Zitieren

APA

Elgedawy, G. A., Elabd, N. S., Salem, R. H., Awad, S. M., Amer, A. A., Torayah, M. M., El-Koa, A. A., Abozeid, M., Montaser, B. A., Aboshabaan, H. S., Abdelkreem, M., & Helal, M. L. (2024). FURIN, IFNL4, and TLR2 gene polymorphisms in relation to COVID-19 severity: a case–control study in Egyptian patients. Infection. https://doi.org/10.1007/s15010-024-02266-1

Vancouver

Elgedawy GA, Elabd NS, Salem RH, Awad SM, Amer AA, Torayah MM, et al. FURIN, IFNL4, and TLR2 gene polymorphisms in relation to COVID-19 severity: a case–control study in Egyptian patients. Infection. 2024. doi:10.1007/s15010-024-02266-1

BibTeX
@article{Elgedawy2024,
  author = {Elgedawy, Gamalat A and Elabd, Naglaa S and Salem, Radwa H and Awad, Samah M and Amer, Amany A and Torayah, Mohammad M and El-Koa, Amal A and Abozeid, Mai and Montaser, Belal A and Aboshabaan, Hind S and Abdelkreem, Mervat and Helal, Marwa L},
  title = {FURIN, IFNL4, and TLR2 gene polymorphisms in relation to COVID-19 severity: a case–control study in Egyptian patients},
  journal = {Infection},
  year = {2024},
  doi = {10.1007/s15010-024-02266-1}
}
Kostenlos starten →